BioCentury | Mar 3, 2014
Financial News

Kerecis completes venture financing

Kerecis Ltd. , Reykjavik, Iceland Business: Dermatology Date completed: 2/21/14 Type: Venture financing Raised: $2 million Investors: NSA Ventures; Omega3; Capital ehf; 1924 ehf; Skogur; Klofningur; Hradfrystihusid-Gunnvor Note: The offering is a series A-3 round. WIR...
BioCentury | Nov 18, 2013
Clinical News

MariGen Omega3 regulatory update

...FDA granted 510(k) clearance to Kerecis' MariGen Omega3 to manage chronic wounds. MariGen Omega3 is a...
...is a collagen matrix containing intact collagen and omega-3 fatty acids derived from fish skin. Kerecis Ltd....
BioCentury | May 6, 2013
Financial News

Kerecis completes venture financing

Kerecis Ltd. , Reykjavik, Iceland Business: Dermatology Date completed: 4/26/13 Type: Venture financing Raised: $900,000 Investors: Existing investors; new investors Note: The series A2 round also includes $100,000 in grants. WIR Staff...
BioCentury | Oct 24, 2011
Clinical News

MariGen Lipid Collagen Matrix dermatology data

...An open-label, Icelandic trial in 10 patients with serious non-healing wounds showed that Kerecis' MariGen Lipid...
...6 of the wounds within 1 year. No adverse events or treatment-related allergies were reported. Kerecis Ltd....
BioCentury | Aug 2, 2010
Company News

Kerecis Ltd., ValaMed Ltd. deal

...The partners will research cell growth in various matrices. Kerecis, which develops tissue regeneration technologies for...
...wound care and abdominal wall reconstruction, said that ValaMed can help evaluate the efficacy of Kerecis'...
...cell proliferation in tissues and improve its cell response technology. Further details were not disclosed. Kerecis Ltd....
Items per page:
1 - 5 of 5
BioCentury | Mar 3, 2014
Financial News

Kerecis completes venture financing

Kerecis Ltd. , Reykjavik, Iceland Business: Dermatology Date completed: 2/21/14 Type: Venture financing Raised: $2 million Investors: NSA Ventures; Omega3; Capital ehf; 1924 ehf; Skogur; Klofningur; Hradfrystihusid-Gunnvor Note: The offering is a series A-3 round. WIR...
BioCentury | Nov 18, 2013
Clinical News

MariGen Omega3 regulatory update

...FDA granted 510(k) clearance to Kerecis' MariGen Omega3 to manage chronic wounds. MariGen Omega3 is a...
...is a collagen matrix containing intact collagen and omega-3 fatty acids derived from fish skin. Kerecis Ltd....
BioCentury | May 6, 2013
Financial News

Kerecis completes venture financing

Kerecis Ltd. , Reykjavik, Iceland Business: Dermatology Date completed: 4/26/13 Type: Venture financing Raised: $900,000 Investors: Existing investors; new investors Note: The series A2 round also includes $100,000 in grants. WIR Staff...
BioCentury | Oct 24, 2011
Clinical News

MariGen Lipid Collagen Matrix dermatology data

...An open-label, Icelandic trial in 10 patients with serious non-healing wounds showed that Kerecis' MariGen Lipid...
...6 of the wounds within 1 year. No adverse events or treatment-related allergies were reported. Kerecis Ltd....
BioCentury | Aug 2, 2010
Company News

Kerecis Ltd., ValaMed Ltd. deal

...The partners will research cell growth in various matrices. Kerecis, which develops tissue regeneration technologies for...
...wound care and abdominal wall reconstruction, said that ValaMed can help evaluate the efficacy of Kerecis'...
...cell proliferation in tissues and improve its cell response technology. Further details were not disclosed. Kerecis Ltd....
Items per page:
1 - 5 of 5